Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jiří, Matuška"'
Autor:
Vladimíra Fejfarová, Jiří Matuška, Edward Jude, Pavlína Piťhová, Milan Flekač, Karel Roztočil, Veronika Wosková, Michal Dubský, Alexandra Jirkovská, Robert Bém, Jitka Husáková, Věra Lánská
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundAll diagnostic procedures of peripheral arterial disease (PAD) in diabetic foot (DF) are complicated due to diabetes mellitus and its late complications.The aim of our study is to enhance diagnosis of PAD using a novel transcutaneous oximet
Externí odkaz:
https://doaj.org/article/4b8cacaf600e4d8ab25611b91dc9e52e
Autor:
Gualtiero Palareti MD, Angelo A. Bignamini MD, Michela Cini PhD, Young-Jun Li MD, Tomasz Urbanek MD, Juraj Madaric MD, Kamel Bouslama MD, German Y. Sokurenko MD, Giuseppe M. Andreozzi MD, Jiří Matuška MD, Armando Mansilha MD, Victor Barinov MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Background International guidelines recommend at least three months anticoagulation in all patients after acute venous thromboembolism (VTE) and suggest those with unprovoked events be considered for indefinite anticoagulation if the risk of recurren
Externí odkaz:
https://doaj.org/article/9dc7d1f96b004974aa66dfd6b56b529e
Autor:
Gualtiero Palareti, Angelo A. Bignamini, Tomasz Urbanek, Michela Cini, Young-Jun Li, Juraj Madaric, Kamel Bouslama, German Y. Sokurenko, Giuseppe M. Andreozzi, Jiří Matuška, Armando Mansilha, Victor Barinov
Publikováno v:
Thrombosis research. 211
Low attention has generally been dedicated to the influence of clinical presentation, extent of venous thrombosis and presence of residual vein obstruction (RVO) on the decision about the duration of secondary prophylaxis after a first venous thrombo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5e972a64c88d2c8de349e5e6c514f9
https://pubmed.ncbi.nlm.nih.gov/35151009
https://pubmed.ncbi.nlm.nih.gov/35151009
Autor:
Gualtiero, Palareti, Angelo, Bignamini, Michela, Cini, Young-Jun, Li, Tomasz, Urbanek, Juraj, Madaric, Kamel, Bouslama, German Y, Sokurenko, Giuseppe M, Andreozzi, Jiří, Matuška, Armando, Mansilha, Victor, Barinov, Chedia, Kechrid
Publikováno v:
Internal and Emergency Medicine
The decision on treatment after a first venous thromboembolism (VTE) to prevent recurrences may be influenced by many factors. The prospective, observational, WHITE study aimed to analyze how this issue was tackled in every-day clinical practice in v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8d3fa929c7fa2ee57ce17d845295c1
https://pubmed.ncbi.nlm.nih.gov/34313959
https://pubmed.ncbi.nlm.nih.gov/34313959
Publikováno v:
Advances in Therapy
Introduction Micro- and macrovascular complications of diabetes are leading morbidities in the world population. They are responsible not only for increased mortality but also severe disabilities, which jeopardize quality of life (e.g., blindness, wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076276ae053485978b4e38d003c5bad7
http://hdl.handle.net/11562/1037279
http://hdl.handle.net/11562/1037279
Publikováno v:
Cor et Vasa. 60:e183-e204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fffc1b59f8ce2966b2689e3b61fb9da5
https://doi.org/10.1016/j.crvasa.2018.01.001
https://doi.org/10.1016/j.crvasa.2018.01.001
Autor:
Jiří Matuška
Publikováno v:
Interní medicína pro praxi. 19:258-261
Žilni tromboembolicka nemoc patři mezi nejzavažnějsi onemocněni oběhoveho systemu se stale rostouci incidenci. Dlouhodoběbyla v terapii věnovana pozornost jen samotne tromboembolicke přihodě, přicemž delka podavani antikogulace bylarelati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::534cf2aec93c72911c33add64f44fb92
https://doi.org/10.36290/int.2017.042
https://doi.org/10.36290/int.2017.042
Autor:
Angelo A. Bignamini, Jiří Matuška
Publikováno v:
Advances in Therapy
Introduction Chronic venous disease (CVD) is a common condition associated with valvular dysfunction, venous hypertension and endothelial inflammation. Sulodexide facilitates the healing of venous ulcers and is frequently used in patients with CVD wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f4af59daa1a8e02881a6e01828c143
https://pubmed.ncbi.nlm.nih.gov/31989486
https://pubmed.ncbi.nlm.nih.gov/31989486
Autor:
Michela Cini, Kamel Bouslama, German Y Sokurenko, Victor Barinov, Angelo A. Bignamini, Jiří Matuška, Juraj Madaric, Armando Mansilha, Tomasz Urbanek, Young-Jun Li, Gualtiero Palareti, Giuseppe M. Andreozzi
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
Background International guidelines recommend at least three months anticoagulation in all patients after acute venous thromboembolism (VTE) and suggest those with unprovoked events be considered for indefinite anticoagulation if the risk of recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9036ebb0a278fa34ecc45c48a256f6b9
https://doi.org/10.1177/10760296211049402
https://doi.org/10.1177/10760296211049402
Autor:
Giuseppe M, Andreozzi, Angelo A, Bignamini, Giovanni, Davì, Gualtiero, Palareti, Jiří, Matuška, Martin, Holý, Katarzyna, Pawlaczyk-Gabriel, Andrej, Džupina, German Y, Sokurenko, Yury P, Didenko, Laurentia D, Andrei, Gianfranco, Lessiani, Adriana, Visonà, Giacomo, Failla
Publikováno v:
Circulation. 132:1891-1897
Background— Patients with a first episode of unprovoked venous thromboembolism have a high risk of recurrence after discontinuation of anticoagulant therapy. Extending anticoagulation reduces the risk of recurrence but is associated with increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78de9e7b9a346d6038abaf4d7bc520d4
https://doi.org/10.1161/circulationaha.115.016930
https://doi.org/10.1161/circulationaha.115.016930